LAMPS as DDT for Hepatic Clearance Submitted to CDER ISTAND

The letter of intent for the LAMPS as a DDT to establish the hepatic clearance of drug candidates in patients with MASLD and assist in the determination of drug candidate dosing in clinical trials when patients with MASLD are included has been accepted into the CDER ISTAND pilot program for qualification. – June 23, 2025.